Searched for
BIOLOGICS DRUG SUBSTANCE
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- DRDO flags rising global CBRN risks, warns of unstable geopolitical orderGlobal security faces growing challenges. DRDO scientist Upendra Kumar Singh stresses the need for stronger preparedness against chemical, ...
- Cocaine pollution in rivers may be affecting salmon behaviour more than scientists expectedResearch reveals cocaine and its metabolite, benzoylecgonine, significantly alter salmon behavior, causing increased travel distances and p...
- Scientists have discovered that cocaine-powered super salmon live longer and swim faster than normal salmonScientists found Atlantic salmon exposed to cocaine swam further and lived longer. This study highlights how drugs in waterways change aqua...
- Samsung Biologics to buy US drug production facility from GSK for $280 millionSamsung Biologics is acquiring its first U.S. drug production facility from GSK for $280 million to meet long-term U.S. market demand. The ...
- Biocon's Bengaluru drug manufacturing facility gets 'Voluntary Action Indicated' classificationBiocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classific...
- Biocon shares rise 2% after USFDA concludes inspection with 5 observationsBiocon shares: The inspection, carried out from August 26 to September 3, 2025, spanned multiple operational areas such as drug substance m...
- Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDABiocon Biologics' drug substance facility in Bengaluru has been classified by the USFDA as voluntary action indicated after a cGMP inspecti...
- Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facilityBiocon shares fell 2% to Rs 361.5 after the USFDA issued four observations following an inspection of its Bengaluru API facility. The compa...
- Strides sells arm's manufacturing unit to Syngene International for Rs 702 croreStrides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene ...
- Biocon Biologics gets EU GMP certification from Ireland's HPRAThe company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certif...
- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- Pfizer to halt biosimilar output in China, sell assets to WuXi BiologicsThe pharmaceutical industry increasingly relies for its profits on costly biologic drugs, made from living organisms that are tougher and m...
- Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licenceThis additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its...
- Biocon plunges 4% as French regulator decides to re-inspect facilityThe re-inspection will be to verify implementation of the proposed corrective and preventive actions, the company said.
- ANSM gives GMP nod to Biocon, to re-inspect drug product unitBiocon, with its partner Mylan, will work with the French and European regulatory authorities with regard to the follow- up inspection of t...
Load More
